Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesThe pragmatic use of apomorphine at the end of life
Palliative Medicine, 10/30/09
Dewhurst F et al. – Parkinson's Disease (PD) is an irreversible degenerative neurological disorder with no known cure. Apomorphine is a potent short–acting D1/D2 dopamine agonist administered sub–cutaneously that is used in the treatment of PD. This case highlights its potential benefits for symptom control at the end of life.
Related Articles
The Effects of Apomorphine on Visual Perception in Patients With Parkinson Disease and Visual Hallucinations: A Pilot Study
Clinical Neuropharmacology, 10/02/09
Relevance Score: 88%
Inhalation Device Allows Novel Administration of Apomorphine in Men with Erectile Dysfunction - Efficacy and Safety Findings
The Journal of Sexual Medicine, 10/30/09
Relevance Score: 87%
The ANKK1 Gene Associated with Addictions Is Expressed in Astroglial Cells and Upregulated by Apomorphine
Biological Psychiatry, 10/28/09
Relevance Score: 83%
Today in Neurology...keeping you current
Receive free subspecialty "5-minute updates" via email
Accumulation of gene polymorphisms related to plaque disruption and thrombosis is associated with cerebral infarction in subjects with type 2 diabetes
Diabetes Care, 11/25/09
Safety and efficacy of deep brain stimulation in refractory cluster headache: a randomized placebo-controlled double-blind trial followed by a 1-year open extension
The Journal of Headache and Pain, 11/25/09
Sacral Nerve Stimulation as a Treatment Modality for Intractable Neuropathic Testicular Pain
Pain Physician, 11/25/09
Sponsor
Article Search
Sponsor